|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2726508 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12735991.7 |
| Date of filing the European patent application | 2012-06-28 | |
| (97) | Date of publication of the European application | 2014-05-07 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-09 |
| (46) | Date of publication of the claims translation | 2017-09-11 |
| (86) | Number | PCT/US2012/044703 |
| Date | 2012-06-28 |
| (87) | Number | WO 2013/003625 |
| Date | 2013-01-03 |
| (30) | Number | Date | Country code |
| 201161502167 P | 2011-06-28 | US | |
| PCT/US2012/0444 | 2012-06-27 | WO |
| (72) |
ROHLFF, Christian, GB
TERRETT, Jonathan, Alexander, US
|
| (73) |
Berlin-Chemie AG,
Glienicker Weg 125-127, 12489 Berlin,
DE
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Antikūnai prieš ADP-ribozilciklazę 2 |
| ANTIBODIES TO ADP-RIBOSYL CYCLASE 2 |
| Payment date | Validity (years) | Amount | |
| 2022-06-21 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-06-28 |